Sign inJoin waitlistJoin the waitlist

Deepak Bhatt

Dean for Clinical Research-Industry Partnerships · Icahn School of Medicine at Mount Sinai

Credentials: · · · · · · · · · · · ·

History

Icahn School of Medicine at Mount Sinai
Present
MOUNT SINAI HEART AND THE CARDIOVASCULAR INSTITUTE Center · Icahn School of Medicine at Mount Sinai
Present
Icahn School of Medicine at Mount Sinai
Present

Interventional Cardiology
1999–2000
Cardiovascular Disease
1996–1999
Internal Medicine
1993–1996
Cornell Univ Joan and Sanford I Weill Med Coll
1989–1993

Research

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine · 2019 · 4,800 citations
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
Circulation · 2011 · 3,926 citations
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal · 2021 · 3,861 citations

GF
Gregg Fonarow
260 papers
Adrian Hernandez
146 papers
Christopher Cannon
143 papers
Eric Peterson
133 papers
LS
Lee Schwamm
119 papers
Robert Harrington
116 papers
GS
Gregg Stone
97 papers
Muthiah Vaduganathan
97 papers · 62 as a fellow
Eric Topol
96 papers
Dominick Angiolillo
90 papers · 7 as a fellow
MS
Marc Sabatine
90 papers
Eric Smith
88 papers

Grants

2/2- Antiplatelet Therapy in Spontaneous Coronary Artery Dissection (APT-SCAD)
National Heart, Lung, and Blood Institute · UG3
PI · $803.7K · Icahn School of Medicine at Mount Sinai
2026–2027

Clinical trials

Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
Principal investigator · Completed · Phase 4
Faculty Hospital Kralovske Vinohrady
2018–2025
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Principal investigator · Completed · Phase 3
AstraZeneca
2014–2019
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Principal investigator · Completed · Phase 3
Amarin Pharma Inc.
2011–2018
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
Principal investigator · Completed
Medtronic Vascular
2011–2017